127 related articles for article (PubMed ID: 18552214)
1. Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation.
Mullighan CG; Heatley SL; Danner S; Dean MM; Doherty K; Hahn U; Bradstock KF; Minchinton R; Schwarer AP; Szer J; Bardy PG
Blood; 2008 Sep; 112(5):2120-8. PubMed ID: 18552214
[TBL] [Abstract][Full Text] [Related]
2. Mannose-binding lectin and infection following allogeneic hemopoietic stem cell transplantation.
Mullighan CG; Bardy PG
Leuk Lymphoma; 2004 Feb; 45(2):247-56. PubMed ID: 15101708
[TBL] [Abstract][Full Text] [Related]
3. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation.
Mullighan CG; Heatley S; Doherty K; Szabo F; Grigg A; Hughes TP; Schwarer AP; Szer J; Tait BD; Bik To L; Bardy PG
Blood; 2002 May; 99(10):3524-9. PubMed ID: 11986203
[TBL] [Abstract][Full Text] [Related]
4. Low pre-transplant levels of mannose-binding lectin are associated with viral infections and mortality after haematopoietic allogeneic stem cell transplantation.
Puente M; Fariñas-Alvarez C; Moreto A; Sánchez-Velasco P; Ocejo-Vinyals JG; Fariñas MC;
BMC Immunol; 2019 Nov; 20(1):40. PubMed ID: 31706269
[TBL] [Abstract][Full Text] [Related]
5. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation.
Granell M; Urbano-Ispizua A; Suarez B; Rovira M; Fernández-Avilés F; Martínez C; Ortega M; Uriburu C; Gaya A; Roncero JM; Navarro A; Carreras E; Mensa J; Vives J; Rozman C; Montserrat E; Lozano F
Exp Hematol; 2006 Oct; 34(10):1435-41. PubMed ID: 16982337
[TBL] [Abstract][Full Text] [Related]
6. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation.
Worthley DL; Johnson DF; Eisen DP; Dean MM; Heatley SL; Tung JP; Scott J; Padbury RT; Harley HA; Bardy PG; Angus PW; Mullighan CG
Clin Infect Dis; 2009 Feb; 48(4):410-7. PubMed ID: 19143554
[TBL] [Abstract][Full Text] [Related]
7. Mannose-binding lectin gene variants and infections in patients receiving autologous stem cell transplantation.
Moreto A; Fariñas-Alvarez C; Puente M; Ocejo-Vinyals JG; Sánchez-Velasco P; Horcajada JP; Batlle A; Montes C; Santos F; Conde E; Fariñas MC
BMC Immunol; 2014 May; 15():17. PubMed ID: 24886325
[TBL] [Abstract][Full Text] [Related]
8. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
9. Mannose-binding lectin 2 polymorphisms do not influence frequency or type of infection in adults with chemotherapy induced neutropaenia.
Wong M; Öhrmalm L; Broliden K; Aust C; Hibberd M; Tolfvenstam T
PLoS One; 2012; 7(2):e30819. PubMed ID: 22363494
[TBL] [Abstract][Full Text] [Related]
10. Mannose-Binding Lectin-Deficient Donors Increase the Risk of Bacterial Infection and Bacterial Infection-Related Mortality After Liver Transplantation.
Lombardo-Quezada J; Sanclemente G; Colmenero J; Español-Rego M; Arias MT; Ruiz P; Mauro E; Sastre L; Crespo G; Rimola A; Moreno A; Lozano F; Navasa M
Am J Transplant; 2018 Jan; 18(1):197-206. PubMed ID: 28649744
[TBL] [Abstract][Full Text] [Related]
11. Mannose-binding lectin gene (MBL2) polymorphisms related to the mannose-binding lectin low levels are associated to dengue disease severity.
Figueiredo GG; Cezar RD; Freire NM; Teixeira VG; Baptista P; Cordeiro M; Carmo RF; Vasconcelos LR; Moura P
Hum Immunol; 2016 Jul; 77(7):571-5. PubMed ID: 27180198
[TBL] [Abstract][Full Text] [Related]
12. Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors.
Neth OW; Bacher U; Das P; Zabelina T; Kabisch H; Kroeger N; Ayuk F; Lioznov M; Waschke O; Fehse B; Thiébaut R; Haston RM; Klein N; Zander AR
Bone Marrow Transplant; 2010 Jan; 45(1):13-9. PubMed ID: 19430499
[TBL] [Abstract][Full Text] [Related]
13. Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation.
Cervera C; Balderramo D; Suárez B; Prieto J; Fuster F; Linares L; Fuster J; Moreno A; Lozano F; Navasa M
Liver Transpl; 2009 Oct; 15(10):1217-24. PubMed ID: 19790141
[TBL] [Abstract][Full Text] [Related]
14. MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation.
Mølle I; Peterslund NA; Thiel S; Steffensen R
Bone Marrow Transplant; 2006 Oct; 38(8):555-60. PubMed ID: 16953214
[TBL] [Abstract][Full Text] [Related]
15. Mannose-binding lectin levels and infections in children after allogeneic hematopoietic SCT.
Chaudhry SH; Chaudhry S; Jansen-Hoogendijk AM; Jol van der Zijde CM; van Tol MJ; Roos A; Bredius RG
Bone Marrow Transplant; 2010 Feb; 45(2):289-93. PubMed ID: 19597428
[TBL] [Abstract][Full Text] [Related]
16. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
Front Immunol; 2018; 9():2153. PubMed ID: 30294330
[TBL] [Abstract][Full Text] [Related]
19. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
Chhabra S; Ahn KW; Hu ZH; Jain S; Assal A; Cerny J; Copelan EA; Daly A; DeFilipp Z; Gadalla SM; Gale RP; Ganguly S; Hamilton BK; Hildebrandt GC; Hsu JW; Inamoto Y; Kanate AS; Khoury HJ; Lazarus HM; Litzow MR; Nathan S; Olsson RF; Pawarode A; Ringden O; Rowe JM; Saad A; Savani BN; Schouten HC; Seo S; Shah NN; Solh M; Stuart RK; Ustun C; Woolfrey AE; Yared JA; Alyea EP; Kalaycio ME; Popat U; Sobecks RM; Saber W
Blood Adv; 2018 Nov; 2(21):2922-2936. PubMed ID: 30396912
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.
Golshayan D; Wójtowicz A; Bibert S; Pyndiah N; Manuel O; Binet I; Buhler LH; Huynh-Do U; Mueller T; Steiger J; Pascual M; Meylan P; Bochud PY;
Kidney Int; 2016 Apr; 89(4):927-38. PubMed ID: 26924055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
